Invention Grant
- Patent Title: Protein involved in ovarian cancer
- Patent Title (中): 涉及卵巢癌的蛋白质
-
Application No.: US13566011Application Date: 2012-08-03
-
Publication No.: US09120860B2Publication Date: 2015-09-01
- Inventor: Nicola Anne Burgess
- Applicant: Nicola Anne Burgess
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: Klauber & Jackson LLC
- Priority: GB0324656.8 20031022
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/53 ; C07K16/30 ; A61K38/17 ; C12Q1/68 ; G01N33/68
Abstract:
The present invention relates to new uses of CDCP1 in the diagnosis, screening, treatment and prophylaxis of ovarian cancer. The invention also provides compositions comprising CDCP1, including vaccines, antibodies that are immunospecific for CDCP1 and agents which interact with or modulate the expression or activity of CDCP1 or which modulate the expression of the nucleic acid which codes for CDCP1.
Public/Granted literature
- US20130230524A1 Protein Involved in Ovarian Cancer Public/Granted day:2013-09-05
Information query
IPC分类:
